Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

C. Gupta · SciRah

Researcher profile · Semantic Scholar

C. Gupta

Share profile

C. Gupta — researcher profile on SciRah

h-index: 10
Works: 26
Citations: 308

Most-cited papers

A new approach to define acute kidney injury in term newborns with hypoxic ischemic encephalopathy
C. Gupta, A. Massaro, P. Ray
2016Pediatric nephrology (Berlin, West)78 citations Open access
Semantic Scholar
Genetic Programming of Hypertension
S. Ahn, C. Gupta
2018Frontiers in Pediatrics37 citations Open access
Semantic Scholar
Long-term Safety and Efficacy of the Anti-MAdCAM-1 Monoclonal Antibody Ontamalimab [SHP647] for the Treatment of Ulcerative Colitis: The Open-label Study TURANDOT II
W. Reinisch, W. Sandborn, S. Danese, X. Hébuterne +14 more
2021Journal of Crohn's & Colitis33 citations Open access
Semantic Scholar
Synergistic activity of IDH1 inhibitor BAY1436032 with azacitidine in IDH1 mutant acute myeloid leukemia
A. Chaturvedi, C. Gupta, R. Gabdoulline, Nora M. Borchert +14 more
2020Haematologica33 citations Open access
Semantic Scholar
In vivo efficacy of mutant IDH1 inhibitor HMS-101 and structural resolution of distinct binding site
A. Chaturvedi, Ramya Goparaju, C. Gupta, J. Weder +13 more
2019Leukemia21 citations Open access
Semantic Scholar
Phase II Study of First‐Line Trebananib Plus Sorafenib in Patients with Advanced Hepatocellular Carcinoma
G. Abou-Alfa, J. Blanc, S. Miles, T. Ganten +12 more
2017The Oncologist21 citations Open access
Semantic Scholar
Outcomes by occurrence of immune-mediated adverse events (imAEs) with tremelimumab (T) plus durvalumab (D) in the phase 3 HIMALAYA study in unresectable hepatocellular carcinoma (uHCC).
G. Lau, A. Cheng, B. Sangro, M. Kudo +15 more
2023Journal of Clinical Oncology17 citations
Semantic Scholar
Low-Dose Antithymocyte Globulin Has No Disadvantages to Standard Higher Dose in Pediatric Kidney Transplant Recipients: Report From the Pediatric Nephrology Research Consortium
I. Ashoor, R. Beyl, C. Gupta, Amrish Jain +7 more
2021Kidney International Reports12 citations Open access
Semantic Scholar
Effective drug treatment identified by in vivo screening in a transplantable patient-derived xenograft model of chronic myelomonocytic leukemia
A. Kloos, Konstantinos Mintzas, Lina Winckler, R. Gabdoulline +15 more
2020Leukemia12 citations Open access
Semantic Scholar
Synergistic Activity of IDH1 Inhibitor Bay-1436032 with Azacitidine in IDH1 Mutant Acute Myeloid Leukemia
A. Chaturvedi, C. Gupta, Ramya Goparaju, R. Gabdoulline +11 more
201710 citations
Semantic Scholar
Temporal patterns of immune-mediated adverse events (imAEs) with tremelimumab (T) plus durvalumab (D) in the phase 3 HIMALAYA study in unresectable hepatocellular carcinoma (uHCC).
G. Lau, B. Sangro, O. Crysler, W. Sukeepaisarnjaroen +14 more
2023Journal of Clinical Oncology8 citations Open access
Semantic Scholar
Phase II study of first-line trebananib plus sorafenib in patients with advanced hepatocellular carcinoma (HCC).
G. Abou-Alfa, J. Blanc, S. Miles, T. Ganten +8 more
20147 citations
Semantic Scholar
Population Pharmacokinetics and Exposure–Response Analysis of Tremelimumab 300 mg Single Dose Combined with Durvalumab 1500 mg Q4W (STRIDE) in Patients with Unresectable Hepatocellular Carcinoma
KyoungSoo Lim, Aburough Abegesah, Chun-xiang Fan, J. He +9 more
2023Journal of clinical pharmacology6 citations Open access
Semantic Scholar
Presence and impact of antidrug antibodies (ADAs) to tremelimumab (T) or durvalumab (D) in the phase 3 HIMALAYA study of unresectable hepatocellular carcinoma (uHCC).
O. Crysler, M. Yarchoan, J. Furuse, P. Galle +9 more
2023Journal of Clinical Oncology5 citations
Semantic Scholar
Renal Transplantation in Children: Current Status and Challenges
C. Gupta, A. Moudgil
20174 citations Open access
Semantic Scholar
Combination treatment of an IDH1 inhibitor with chemotherapy in IDH1 mutant acute myeloid leukemia
C. Gupta, S. Kaulfuss, Kerstin Görlich, Basem Othman +2 more
2020Annals of Hematology3 citations Open access
Semantic Scholar
772 Long-Term Mucosal Healing, Clinical Response and Clinical Remission in Patients With Ulcerative Colitis Treated With the Anti-MAdCAM-1 Antibody Ontamalimab: Results From the Open-Label Extension Study TURANDOT II
S. Danese, W. Sandborn, W. Reinisch, X. Hébuterne +13 more
2019American Journal of Gastroenterology1 citations
Semantic Scholar
Tu1737 – Efficacy of the Anti-Mucosal Addressin Cell Adhesion Molecule-1 (MADCAM-1) Antibody Shp647 in Ulcerative Colitis: Results from the Open-Label Extension Study Turandot Ii
W. Reinisch, W. Sandborn, S. Danese, X. Hébuterne +13 more
2019Gastroenterology1 citations Open access
Semantic Scholar
Correction: Effective drug treatment identified by in vivo screening in a transplantable patient-derived xenograft model of chronic myelomonocytic leukemia
A. Kloos, Konstantinos Mintzas, Lina Winckler, R. Gabdoulline +15 more
2021Leukemia0 citations Open access
Semantic Scholar
Tu1738 – Biomarker and Pharmacokinetic Data from the Turandot Ii Open-Label Extension Study of the Anti-Mucosal Addressin Cell Adhesion Molecule-1 (MADCAM-1) Antibody Shp647 in Patients with Ulcerative Colitis
W. Reinisch, W. Sandborn, S. Danese, X. Hébuterne +13 more
2019Gastroenterology0 citations
Semantic Scholar
Efficacy of Chemotherapy, Phd-Inhibitor Molidustat or BRD4 Inhibitor JQ1 in Combination with Targeted Inhibition of Mutated IDH1 in Human AML In Vivo
A. Chaturvedi, C. Gupta, S. Kaulfuss, Basem Othman +8 more
2019Blood0 citations Open access
Semantic Scholar
Crystal structure of IDH1 R132H in complex with HMS101
A. Chaturvedi, R. Goparaju, C. Gupta, T. Kluenemann +8 more
20190 citations
Semantic Scholar
P081 Rapid Symptomatic Remission in Patients With Ulcerative Colitis Treated With the Anti-MAdCAM-1 Antibody Ontamalimab: Results From TURANDOT and TURANDOT II
S. Danese, W. Sandborn, W. Reinisch, X. Hébuterne +14 more
20190 citations
Semantic Scholar
Signaling Pathways of Mutant IDH1 Independent of R-2-Hydroxyglutarate
C. Gupta, M. M. Araujo-Cruz, N. Jyotsana, Amit Sharma +9 more
2018Blood0 citations Open access
Semantic Scholar
2018 Genetic Programming of Hypertension
S. Ahn, C. Gupta
20180 citations
Semantic Scholar
Induction Therapy in Pediatric Renal Transplantation: Current Perspective
A. Moudgil, C. Gupta
20130 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Heuser×9
Invite
M. Heuser — researcher profile on SciRah
A. Ganser×8
Invite
A. Ganser — researcher profile on SciRah
A. Chaturvedi×7
Invite
A. Chaturvedi — researcher profile on SciRah
R. Schottmann×7
Invite
R. Schottmann — researcher profile on SciRah

×5

Invite

W. Reinisch — researcher profile on SciRah

Invite

W. Sandborn — researcher profile on SciRah

Invite

S. Danese — researcher profile on SciRah

X. Hébuterne×5

Invite

X. Hébuterne — researcher profile on SciRah

M. Kłopocka×5

Invite

M. Kłopocka — researcher profile on SciRah

Invite

D. Tarabar — researcher profile on SciRah

T. Vaňásek×5

Invite

T. Vaňásek — researcher profile on SciRah

Invite

M. Greguš — researcher profile on SciRah